- About Breast Cancer
- Community Impact
- 2019 More Than Pink Walk
- Get Involved
Visionary Awards Luncheon
Join us on February 22, 2019 at the Julia Morgan Ballroom to honor Bay Area individuals who have made important advancements in medical research focused on breast cancer and Bay Area philanthropists who have generously donated to breast cancer and education programs.
Julia Morgan Ballroom
465 California St, San Francisco, CA 94104
11:00 Reception & Silent Auction
12:00 Luncheon and Program
Please join us in celebrating Bay Area Visionaries!
Can’t attend? Donate today and help us support breast cancer patients in the Bay Area.
Visionary Award Recipients
Melinda Telli, M.D. Stanford University School of Medicine
Eileen T. Consorti, M.D. Alta Bates Summit Medical Center
Pamela Munster, M.D. University of California, San Francisco
Philanthropist Award Recipients
Patrick Barber, Compass
Mario Diaz, Wells Fargo Bank
Pam Judd Award Recipient
Emmy Award winning broadcaster, Jan Yanehiro.
Our work is not done. Support of this event will help us reach our Bold Goal of reducing the current number of breast cancer deaths by 50% in the United States by 2026.
Funds raised at the Visionary Awards Luncheon will be invested in the Komen Treatment Assistance Fund. The Treatment Assistance Fund aims to help those who are facing financial challenges by providing limited financial assistance, education, and support services to low-income, underinsured or uninsured individuals in the eight counties that we serve; Alameda, Contra Costa, Marin, Napa, San Francisco, San Mateo, Santa Clara, and Sonoma counties. Funding helps patients of any age who have been diagnosed with breast cancer, at any stage of the disease.
In addition, 25 percent of funds raised at the Visionary Award Luncheon will be invested in the national Komen Grants Program, which funds groundbreaking breast cancer research, meritorious awards and educational and scientific programs around the world. In 2014-15, Bay Area breast cancer researchers received more than $1.4 million from the Komen Research, Evaluation and Scientific Program.